Tags |
|
|
Links |
|
|
Main Subject - Business Ethics: An Oxymoron?
Why do I believe good PR and business ethics are inextricably lin
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ked? It comes down to definitions. Ethics is learning what is rig
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
t and what is wrong and then doing the "right thing." PR involves
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
providing counsel on the "right thing" to do and then helping th
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
organization get credit for it.
The business and political exce
The business and political exce
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ss of the last 10 years have taken some PR practitioners to the d
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
rk side because they felt it was the only way for their company t
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
o profit. Although I personally believe doing right for right's s
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ke is enough, there are some who may not share this view. OK, her
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
e's a reason that any good capitalist can embrace: research now s
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ows that socially responsible behavior is good for the bottom lin
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
e.
A recent analysis of overall financial performance of the 200
A recent analysis of overall financial performance of the 200
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
list of 100 Best Corporate Citizens shows that this group of fir
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ms did significantly better than the remaining companies of the S
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
P 500. Professors at DePaul University found that the mean rankin
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
g of the 100 Best was more than 10 percentile higher than the oth
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
r firms of the S&P 500.
Additionally, they had a significantly b
Additionally, they had a significantly b
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
etter reputation among corporate directors and security analysts
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ased upon results of the Fortune Magazine survey of most admired
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
companies.
So, you see, it really does pay to do the right thing
So, you see, it really does pay to do the right thing
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/19042/mainsubjects-Business-Ethics-An-Oxymoron.html">Business Ethics: An Oxymoron?</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/19042/mainsubjects-Business-Ethics-An-Oxymoron.html]Business Ethics: An Oxymoron?[/url]
Related Articles:
Using the Power of Client Testimonials to Grow Your Business
Professional Commercial Printing Services
Bookmark it:
|